Renaissance Technologies
OKYO

Renaissance Technologies’s OKYO Pharma OKYO Stock Holding History

Renaissance Technologies’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-138,000
Closed -$286K – 3560
2025
Q4 		$286K Buy
138,000
+96,800
+235% +$210K ﹤0.01% 2780
2025
Q3 		$82.4K Buy
+41,200
New +$105K ﹤0.01% 3278
2025
Q2 		– Sell
-13,946
Closed -$17.7K – 3798
2025
Q1 		$17.7K Sell
13,946
-2,554
-15% -$3.06K ﹤0.01% 3365
2024
Q4 		$19K Buy
+16,500
New +$17.7K ﹤0.01% 3486
2024
Q1 		– Sell
-11,800
Closed -$21K – 3963
2023
Q4 		$21K Sell
11,800
-4,547
-28% -$7.98K ﹤0.01% 3574
2023
Q3 		$30K Buy
+16,347
New +$27.5K ﹤0.01% 3470

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM

Renaissance Technologies's OKYO Position: Q1 2026 in Review

Renaissance Technologies sold out of OKYO Pharma (OKYO) in Q1 2026, closing a stake of 138,000 shares — an estimated $286K sold.

Renaissance Technologies first reported a position in OKYO in Q3 2023 and held it in 6 quarters. The position peaked at $286K in Q4 2025. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Renaissance Technologies reported no remaining OKYO Pharma position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 138,000 OKYO Pharma shares in Q1 2026, an estimated $286K.
  • Renaissance Technologies first reported a position in OKYO Pharma in Q3 2023 and held it in 6 quarters.
  • Renaissance Technologies's OKYO Pharma position peaked at $286K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.